novocure  therapy for solid tumors called tumor treating fields search contact us careers news and media more than ‘thinkingoutside of the box’ our general manager germany tobias weizel said he feels lucky to be a part of novocure’s mission of bringing a profoundly different cancer treatment to patients worldwide learn more a decade of working for novocure sharyn ruperti clinical trial manager discusses her lengthy career at novocure read about her views on the evolution of the company and what sets us apart learn more the science of research our director of science ze’ev bomzon discusses his research on tumor treating fields and the importance of effectively explaining the technology learn more  novocure annual report view our  annual report to learn where weve been and where we are headed in  and beyond learn more mechanism of action mechanism of action tumor treating fields or ttfields are low intensity alternating electric fields that disrupt cell division through physical interactions with key molecules during mitosis our noninvasive treatment targets solid tumors join our team join our team we count on the contributions of our talented team members who are committed to improving the lives of cancer patients we seek high performers who thrive in fastpaced environments and are inspired by making a difference in cancer care treating cancer with electric fields treating cancer with electric fields surgery chemotherapy and radiation are the bestknown methods for treating cancer at tedmed in  our executive chairman bill doyle presents our therapy tumor treating fields as a potential fourth modality in cancer care novocure news the story of novocure in  our founder professor yoram palti sought to leverage his expertise in biophysics to develop a new way to treat cancer that would destroy tumor cells while sparing healthy tissue and avoiding many of the lifealtering side effects of existing cancer therapies novocure has grown into an international oncology company with more than  employees and operations in the us europe and asia learn more tumor treating fields or ttfields are low intensity alternating electric fields ttfields disrupt cancer cell division through physical interactions with key molecules during mitosis our noninvasive treatment targets solid tumors our therapy explore our clinical pipeline our research shows that ttfields have an antimitotic effect in more than  solid tumor types in culture and in eight in vivo tumor models our pipeline we are dedicated to improving the lives of cancer patients patients remain at the heart of the work we do every day learn more about our patients their families and the people working to deliver patientforward therapies to treat cancer patientforward about us corporate timeline professor yoram palti founded novocure in  we have since accomplished many significant milestones leadership meet our leaders who have extensive experience across oncology biotechnology and medical device industries corporate presentation we pioneer a profoundly different approach to treating cancer called tumor treating fields our therapy mechanism of action our proprietary technology – tumor treating fields – disrupts cell division through physical interactions with key molecules during mitosis delivery method we deliver tumor treating fields through a noninvasive portable medical device that targets solid tumors with no known systemic toxicities treating cancer with electric fields treatment with tumor treating fields has become a fourth modality in cancer care our pipeline clinical trials our mechanism of action is broadly applicable across a variety of solid tumors publications we have more than  years of research and multiple peerreviewed publications with preclinical data in  cancer types and clinical data in eight cancer types novocuretrialcom the science of tumor treating fields extends beyond glioblastoma we are conducting clinical trials in brain metastases nonsmall cell lung cancer pancreatic cancer ovarian cancer and mesothelioma patientforward news and media media gallery featured stories investor relations press releases corporate presentation events annual reports sec filings stock information corporate governance faq email alerts careers working with us our locations current job listings novocure ltd nvcr  product pipeline analysis  update about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in life sciences»biotechnology»biotechnology company reports novocure ltd nvcr  product pipeline analysis  update lowest prices guaranteed length publisher published date sku from   pages globaldata december  gbdt lowest prices guaranteed price from  length  pages publisher globaldata published date december  sku gbdt table of contents close window table of contents novocure ltd nvcr  product pipeline analysis  update printer format globaldata novocure ltd company overview novocure ltd company snapshot novocure ltd pipeline products and clinical trials overview novocure ltd – pipeline analysis overview key facts novocure ltd  major products and services novocure ltd pipeline products by development stage novocure ltd clinical trials by trial status novocure ltd pipeline products overview optune  brain metastasis optune  brain metastasis product overview optune  brain metastasis clinical trial optune  breast cancer optune  breast cancer product overview optune  cervical cancer optune  cervical cancer product overview optune  colorectal carcinoma optune  colorectal carcinoma product overview optune  gastric adenocarcinoma optune  gastric adenocarcinoma product overview optune  hepatocellular carcinoma optune  hepatocellular carcinoma product overview optune  liver metastases optune  liver metastases product overview optune  malignant melanoma optune  malignant melanoma product overview optune  mesothelioma optune  mesothelioma product overview optune  ovarian cancer optune  ovarian cancer product overview optune  pancreatic cancer optune  pancreatic cancer product overview optune  prostate cancer optune  prostate cancer product overview optune  renal adenocarcinoma optune  renal adenocarcinoma product overview optune  small cell lung cancer optune  small cell lung cancer product overview optune  squamous nonsmall cell lung cancer optune  squamous nonsmall cell lung cancer product overview optune  urinary transitional cell carcinoma optune  urinary transitional cell carcinoma product overview novocure ltd  key competitors novocure ltd  key employees novocure ltd  key employee biographies novocure ltd  locations and subsidiaries head office other locations  subsidiaries recent developments novocure ltd recent developments dec   novocure’s optune novottfa approved in japan for the treatment of newly diagnosed glioblastoma dec   novocure presents second cohort of phase  pilot panova trial results suggesting tumor treating fields plus nabpaclitaxel and gemcitabine may be safe as firstline treatment and may improve oneyear survival rate of patients with advanced pancreatic dec   novocure presents phase  pilot innovate trial results suggesting tumor treating fields plus paclitaxel may be safe as firstline treatment and may improve survival of patients with recurrent ovarian cancer dec   novocure announces agenda for research and development day on dec   nov   longterm analysis of all  patients enrolled in novocure’s phase  pivotal trial in newly diagnosed glioblastoma confirms successful interim analysis results and demonstrates superior two and fouryear survival rates nov   united healthcare issues positive coverage decision for optune nov   novocure reports third quarter  financial results and provides company update oct   novocure enrolls first patient in phase  pivotal brain metastases trial sep   cns oncology publishes tumor treating fields treatment planning and patient followup guidelines in glioblastoma sep   novocure’s executive chairman william doyle to present on tumor treating fields at new york academy of sciences’ symposium on bioelectronic medicine appendixmethodology about globaldata contact us disclaimer list of tablesnovocure ltd pipeline products and clinical trials overview novocure ltd pipeline products by equipment type novocure ltd pipeline products by indication novocure ltd clinical trials by trial status novocure ltd key facts novocure ltd major products and services novocure ltd number of pipeline products by development stage novocure ltd pipeline products summary by development stage novocure ltd clinical trials by trial status novocure ltd clinical trials summary optune  brain metastasis  product status optune  brain metastasis  product description optune  brain metastasis  a phase ii randomized study of ttfield therapy  khz versus supportive care in nonsmall cell lung cancer patients with  brain metastases following optimal standard local treatment optune  brain metastasis  pilot study of optune novottfa for recurrent atypical and anaplastic meningioma optune  brain metastasis  pivotal openlabel randomized study of radiosurgery with or without tumor treating fields ttfields khz for  brain metastases from nonsmall cell lung cancer nsclc optune  breast cancer  product status optune  breast cancer  product description optune  cervical cancer  product status optune  cervical cancer  product description optune  colorectal carcinoma  product status optune  colorectal carcinoma  product description optune  gastric adenocarcinoma  product status optune  gastric adenocarcinoma  product description optune  hepatocellular carcinoma  product status optune  hepatocellular carcinoma  product description optune  liver metastases  product status optune  liver metastases  product description optune  malignant melanoma  product status optune  malignant melanoma  product description optune  mesothelioma  product status optune  mesothelioma  product description optune  ovarian cancer  product status optune  ovarian cancer  product description optune  pancreatic cancer  product status optune  pancreatic cancer  product description optune  prostate cancer  product status optune  prostate cancer  product description optune  renal adenocarcinoma  product status optune  renal adenocarcinoma  product description optune  small cell lung cancer  product status optune  small cell lung cancer  product description optune  squamous nonsmall cell lung cancer  product status optune  squamous nonsmall cell lung cancer  product description optune  urinary transitional cell carcinoma  product status optune  urinary transitional cell carcinoma  product description novocure ltd key employees novocure ltd key employee biographies table  novocure ltd other locations novocure ltd subsidiaries list of figuresnovocure ltd pipeline products by development stage novocure ltd clinical trials by trial status description close window description novocure ltd nvcr  product pipeline analysis  update printer format globaldata summarynovocure ltd novocure is an oncology company that focuses on the development and commercialization of novel therapies for tumor treating fields the company’s pipeline products find application in various types of cancer indications such as ovarian cancer malignant melanoma hepatocellular carcinoma breast cancer and small cell lung cancer among others novocure also offers products for other indications such as glioblastoma and diagnosed glioblastoma the company operates along with its subsidiaries located in new hampshire the us and berlin germany it owns and operates a research centre in haifa israel the company also has presence in japan and switzerland novocure is headquartered in jersey the ukthis report is a source for data analysis and actionable intelligence on the company’s portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescopethe report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developmentsthe report analyzes all pipeline products in development for the company novocure ltdthe report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial statusthe report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch datethe report provides detailed description of products in development technical specification and functionsthe report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buydevelop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscapedesign and develop your product development marketing and sales strategies by understanding the competitor portfolioto formulate effective research  development strategiesdevelop marketentry and market expansion strategiesexploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust returnplan mergers and acquisitions effectively by identifying key players of the most promising pipeline identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantagedevelop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials stage and of development etcidentify understand and capitalize the next highvalue products that your competitor would add in its portfolio search inside this report close window search inside this report online download  purchase site license  purchase global site license  purchase   research assistance us  intl  download our ebook how to succeed using market research learn how to effectively navigate the market research process to help guide your organization on the journey to success download ebook share this report other tasks printer format order by fax currency converter market report novocure ltd nvcr  product pipeline analysis  update about us • publishers • contact us • cart login  register all industries business  finance  business  financial services  insurance  marketing consumer  food  beverages  consumer goods  food  retailing healthcare  biotechnology  healthcare  medical devices  pharmaceuticals heavy industry  construction  energy  manufacturing  materials  transportation internet  media  ebusiness  internet  media  publishing public sector  defense  education  government telecom  computing  computer technology  fixed networks  software  wireless companycountry reports  company reports  country reports  regional reports   processing novocure ltd nvcr  product pipeline analysis  update dec    globaldata   pages  usd  click here to open the popup youve added the following report to your cartclose cart summary total items subtotal      report summary table of contents companies request details related novocure ltd novocure is an oncology company that focuses on the development and commercialization of novel therapies for tumor treating fields the companys pipeline products find application in various types of cancer indications such as ovarian cancer malignant melanoma hepatocellular carcinoma breast cancer and small cell lung cancer among others novocure also offers products for other indications such as glioblastoma and diagnosed glioblastoma the company operates along with its subsidiaries located in new hampshire the us and berlin germany it owns and operates a research centre in haifa israel the company also has presence in japan and switzerland novocure is headquartered in jersey the ukthis report is a source for data analysis and actionable intelligence on the companys portfolio of pipeline products the report provides key information about the company its major products and brandsthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagereport scopethe report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developmentsthe report analyzes all pipeline products in development for the company novocure ltdthe report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial statusthe report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch datethe report provides detailed description of products in development technical specification and functionsthe report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to get this reportdevelop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscapedesign and develop your product development marketing and sales strategies by understanding the competitor portfolioto formulate effective research  development strategiesdevelop marketentry and market expansion strategiesexploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust returnplan mergers and acquisitions effectively by identifying key players of the most promising pipelineidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantagedevelop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials stage and of development etcidentify understand and capitalize the next highvalue products that your competitor would add in its portfolio table of contentstable of contents list of tables list of figures novocure ltd company overview novocure ltd company snapshot novocure ltd pipeline products and clinical trials overview novocure ltd  pipeline analysis overview key facts novocure ltd  major products and services novocure ltd pipeline products by development stage novocure ltd clinical trials by trial status novocure ltd pipeline products overview optune  brain metastasis optune  brain metastasis product overview optune  brain metastasis clinical trial optune  breast cancer optune  breast cancer product overview optune  cervical cancer optune  cervical cancer product overview optune  colorectal carcinoma optune  colorectal carcinoma product overview optune  gastric adenocarcinoma optune  gastric adenocarcinoma product overview optune  hepatocellular carcinoma optune  hepatocellular carcinoma product overview optune  liver metastases optune  liver metastases product overview optune  malignant melanoma optune  malignant melanoma product overview optune  mesothelioma optune  mesothelioma product overview optune  ovarian cancer optune  ovarian cancer product overview optune  pancreatic cancer optune  pancreatic cancer product overview optune  prostate cancer optune  prostate cancer product overview optune  renal adenocarcinoma optune  renal adenocarcinoma product overview optune  small cell lung cancer optune  small cell lung cancer product overview optune  squamous nonsmall cell lung cancer optune  squamous nonsmall cell lung cancer product overview optune  urinary transitional cell carcinoma optune  urinary transitional cell carcinoma product overview novocure ltd  key competitors novocure ltd  key employees novocure ltd  key employee biographies novocure ltd  locations and subsidiaries head office other locations  subsidiaries recent developments novocure ltd recent developments dec   novocures optune novottfa approved in japan for the treatment of newly diagnosed glioblastoma dec   novocure presents second cohort of phase  pilot panova trial results suggesting tumor treating fields plus nabpaclitaxel and gemcitabine may be safe as firstline treatment and may improve oneyear survival rate of patients with advanced pancreatic dec   novocure presents phase  pilot innovate trial results suggesting tumor treating fields plus paclitaxel may be safe as firstline treatment and may improve survival of patients with recurrent ovarian cancer dec   novocure announces agenda for research and development day on dec   nov   longterm analysis of all  patients enrolled in novocures phase  pivotal trial in newly diagnosed glioblastoma confirms successful interim analysis results and demonstrates superior two and fouryear survival rates nov   united healthcare issues positive coverage decision for optune nov   novocure reports third quarter  financial results and provides company update oct   novocure enrolls first patient in phase  pivotal brain metastases trial sep   cns oncology publishes tumor treating fields treatment planning and patient followup guidelines in glioblastoma sep   novocures executive chairman william doyle to present on tumor treating fields at new york academy of sciences symposium on bioelectronic medicine appendix methodology about globaldata contact us disclaimer list of tablesnovocure ltd pipeline products and clinical trials overview novocure ltd pipeline products by equipment type novocure ltd pipeline products by indication novocure ltd clinical trials by trial status novocure ltd key facts novocure ltd major products and services novocure ltd number of pipeline products by development stage novocure ltd pipeline products summary by development stage novocure ltd clinical trials by trial status novocure ltd clinical trials summary optune  brain metastasis  product status optune  brain metastasis  product description optune  brain metastasis  a phase ii randomized study of ttfield therapy  khz versus supportive care in nonsmall cell lung cancer patients with  brain metastases following optimal standard local treatment optune  brain metastasis  pilot study of optune novottfa for recurrent atypical and anaplastic meningioma optune  brain metastasis  pivotal openlabel randomized study of radiosurgery with or without tumor treating fields ttfields khz for  brain metastases from nonsmall cell lung cancer nsclc optune  breast cancer  product status optune  breast cancer  product description optune  cervical cancer  product status optune  cervical cancer  product description optune  colorectal carcinoma  product status optune  colorectal carcinoma  product description optune  gastric adenocarcinoma  product status optune  gastric adenocarcinoma  product description optune  hepatocellular carcinoma  product status optune  hepatocellular carcinoma  product description optune  liver metastases  product status optune  liver metastases  product description optune  malignant melanoma  product status optune  malignant melanoma  product description optune  mesothelioma  product status optune  mesothelioma  product description optune  ovarian cancer  product status optune  ovarian cancer  product description optune  pancreatic cancer  product status optune  pancreatic cancer  product description optune  prostate cancer  product status optune  prostate cancer  product description optune  renal adenocarcinoma  product status optune  renal adenocarcinoma  product description optune  small cell lung cancer  product status optune  small cell lung cancer  product description optune  squamous nonsmall cell lung cancer  product status optune  squamous nonsmall cell lung cancer  product description optune  urinary transitional cell carcinoma  product status optune  urinary transitional cell carcinoma  product description novocure ltd key employees novocure ltd key employee biographies table  novocure ltd other locations novocure ltd subsidiaries list of figuresnovocure ltd pipeline products by development stage novocure ltd clinical trials by trial status  companies mentioned in this reportvernalis plcoxford biomedica plcergomed plcbeigene ltd this report does not have a press release associated with it order today format pdf  usd license single user delivery by email   business day the fast market research advantage only the best all of our research is sourced from the most trusted and established global analysts and consultancies client focused from startups to multinationals we focus on providing the right research to our diverse client base shop securely our usbased customer service team and ecommerce systems adhere to the highest data security standards industryleading customer support individualized assistance from our expert staff is never more than an email or phone call away best price guarantee we are committed to providing the best research at the lowest cost we will match any published price for the same report guaranteed easy ordering once you’ve found the right report click ‘order now’ and complete the checkout process using any major credit card check or wirebank transferneed multiuser or enterprise license pricing contact us for a custom quote about the publisher globaldata is a leading provider of global business intelligence including market competitor product and customer information it provides indepth research analysis data and forecasts through a range of interactive online databases reports and management briefings globaldata has a large team of experienced research and analysis consulting and marketing experts it has a global presence including key offices in the us europe and asia the group has over  years of experience of delivering market intelligence data and analysis and a highly experienced senior management team publisher details privacy policy  terms of use  flashalerts copyright copy  fast market research inc novocure ltd company profile  bloomberg feedback novocure ltd public company company profile sector health care industry medical equipment  devices subindustry medical devices novocure limited is an oncology company the company researches and develops novel technologies for the treatment of cancer novocure serves the healthcare industry worldwide corporate information address le masurier house la rue le masurier saint helier je ye jersey channel islands phone  fax  web url wwwnovocurecom board members chairman company william doyle novocure ltd vice chairman company kinyip leung novocure ltd lead director company chief executive officer company asaf danziger novocure ltd ctofounder company yoram palti novocure ltd board members company robert mylod redfin corp william burkoth pfizer venture investments llc show more from the web nvcr news press releases pershing square says doyle leaving firm amid novocure demands may   novocure reports second quarter  financial results and provides company update  hours ago novocure™ announces a phase b clinical trial to evaluate the safety of marizomib and temozolomide in combination with jul   novocure’s optune® now available at more than  cancer treatment centers in the us jul   data on delivery of tumor treating fields to be presented at the th annual international conference of the ieee engineering in jul   novocure to report second quarter  financial results jun   novocure to present three abstracts on tumor treating fields and pancreatic cancer at the european society for medical oncology jun   novocure announces change to presentation time at the jmp securities  life sciences conference jun   first patient enrolled in rtog trial of optune® together with bevacizumab for patients with bevacizumabrefractory recurrent jun   key executives william f doyle bill chairman wilhelmus groenhuysen wilco chief financial officer asaf danziger chief executive officer michael ambrogi mike chief operating officer eilon kirson chief science officer yoram palti ctofounder todd longsworth chief compliance ofcgen cnsl pritesh shah sr vpamericas thomas hefti vpeurope  emerging markets ashley cordova investor relations show more show less sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data novocure ltd nvcr  medical equipment  deals and alliances profile sales and support     uk     us infomarketpublisherscom business  finance retail retail consumer goods food  beverage industry chemicals it  technology life sciences services about faq my cart market reports pressreleases events about us terms  conditions customer faq market research reports company reports novocure ltd nvcr  medical equipment  deals and alliances profile date july   pages  price us  license  single user price  us  site license price  us  enterprisewide price globalsitelicense  us  publisher globaldata report type strategic report delivery email delivery pdf id nbedben leaflet download pdf leaflet abstracts contents list of tables list of figures summarynovocure ltd novocure is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields the company’s pipeline products find application in various types of cancer indications such as ovarian cancer malignant melanoma hepatocellular carcinoma breast cancer and small cell lung cancer among others it also offers products for other indications such as glioblastoma and diagnosed glioblastoma novocure operates along with its subsidiaries located in new hampshire the us and berlin germany the company owns and operates a research centre in haifa israel it also has presence in japan and switzerland novocure is headquartered in jersey the uknovocure ltd nvcr  medical equipment  deals and alliances profile provides you comprehensive data and trend analysis of the companys mergers and acquisitions mas partnerships and financings the report provides detailed information on mergers and acquisitions equitydebt offerings private equity venture financing and partnership transactions recorded by the company over a five year period the report offers detailed comparative data on the number of deals and their value categorized into deal types subsector and regionsglobaldata derived the data presented in this report from proprietary inhouse medical etrack deals database and primary and secondary researchscopefinancial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnershipsdeals by year  chart and table displaying information encompassing the number of deals and value reported by the company by year for a five year perioddeals by type  chart and table depicting information including the number of deals and value reported by the company by type such as mergers and acquisitions equitydebt offering etcdeals by region  chart and table presenting information on the number of deals and value reported by the company by region which includes north america europe asia pacific the middle east and africa and south and central americadeals by subsector  chart and table showing information on the number of deals and value reported by the company by subsectormajor deals  information on the companys major financial deals each such deal has a brief summary deal type deal rationale and deal financials and target company’s major public companies key financial metrics and ratiosbusiness description  a brief description of the companys operationskey employees  a list of the key executives of the companyimportant locations and subsidiaries  a list and contact details of key centers of operation and subsidiaries of the companykey competitors  a list of the key competitors of the companykey recent developments  a brief on recent news about the companyreasons to buyget detailed information on the companys financial deals that enable you to understand the companys expansiondivestiture and fund requirementsthe profile enables you to analyze the companys financial deals by region by year by business segments and by type for a five year periodunderstand the companys business segments expansiondivestiture strategythe profile presents deals from the companys core business segments perspective to help you understand its corporate strategyaccess elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the companydetailed information on major recent deals includes a summary of each deal deal type deal rationale deal financials and target companys key financial metrics and ratiosequip yourself with detailed information about the company’s operations to identify potential customers and suppliersthe profile analyzes the companys business structure locations and subsidiaries key executives and key competitorsstay uptodate on the major developments affecting the companyrecent developments concerning the company presented in the profile help you track important eventsgain key insights into the company for academic or business researchkey elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needsnote some sections may be missing if data is unavailable for the company novocure ltd medical equipment deals by year  to ytd novocure ltd medical equipment deals by type  to ytd novocure ltd medical equipment deals by region  to ytd novocure ltd medical equipment deals by market  to ytd novocure ltd medical equipment deals summary  to ytd novocure ltd medical equipment deal detailsventure financingnovocure secures usd million from pharmakonequity offeringnovocure announces partial exercise of underwriter’s option for ipo for usd millionnovocure raises usd million in public offering of series j sharesnovocure raises usd million in public offering of series i sharesnovocure raises usd million in public offering of series h sharesnovocure raises usd million in public offering of sharesnovocure ltd  key competitorskey employeeslocations and subsidiarieshead officeother locations  subsidiariesrecent developmentsfinancial announcementsapr   novocure reports first quarter  financial results and provides company updatenov   novocure reports third quarter  financial results and provides company updatejul   novocure reports second quarter  financial results and provides company updatecorporate communicationsmay   martin j madden joins novocure board of directorsmay   novocure enters into employment agreement with william doyleproduct newsjul   data on delivery of tumor treating fields to be presented at the th annual international conference of the ieee engineering in medicine and biology societydec   novocure announces agenda for research and development day on dec  jul   novocure to host research and development day on dec  mar   red journal publishes data supporting personalized treatment planning to increase ttfields efficacy for patients with glioblastomamar   humana issues positive coverage decision for optunefeb   anthem issues positive coverage decision for optune in newly diagnosed glioblastomaappendixmethodologyabout globaldatacontact usdisclaimer list of tablesnovocure ltd medical equipment key facts novocure ltd medical equipment deals summary  to ytd novocure ltd medical equipment deals by year  to ytd novocure ltd medical equipment deals by type  to ytd novocure ltd medical equipment deals by region  to ytd novocure ltd deals by market  to ytd novocure ltd medical equipment deals summary  to ytd novocure secures usd million from pharmakonnovocure announces partial exercise of underwriter’s option for ipo for usd millionnovocure raises usd million in public offering of series j sharesnovocure raises usd million in public offering of series i sharesnovocure raises usd million in public offering of series h sharesnovocure raises usd million in public offering of sharesnovocure ltd key competitorsnovocure ltd key employeesnovocure ltd other locationsnovocure ltd subsidiaries list of figuresnovocure ltd medical equipment deals by type  to ytd novocure ltd medical equipment deals by year  to ytd novocure ltd medical equipment deals by region  to ytd novocure ltd medical equipment deals by market  to ytd novocure ltd medical equipment deals by year  to ytd novocure ltd medical equipment deals by type  to ytd novocure ltd medical equipment deals by region  to ytd novocure ltd medical equipment deals by market  to ytd  skip to top more publications ergoresearch ltd erg  medical equipment  deals and alliances profile us  jul  ·  pages medikit co ltd   medical equipment  deals and alliances profile us  nov  ·  pages medigus ltd mdgs  medical equipment  deals and alliances profile us  aug  ·  pages nikkiso co ltd   medical equipment  deals and alliances profile us  nov  ·  pages tissue regenix ltd trx  medical equipment  deals and alliances profile us  jul  ·  pages ask your question novocure ltd nvcr  medical equipment  deals and alliances profile company name contact person phonefax email request invoice your enquiry please click on a check box below to confirm you are not a robot market reports all categories sales and support         infomarketpublisherscom   marketpublisherscom about us our clients our publishers customer faq market reports new publications reports by regions pressreleases terms  conditions privacy policy return policy affiliate program join as publisher follow us novocure ltd nvcr  product pipeline analysis  update trends share size research report uscanada toll free home globaldata medical equipments novocure ltd nvcr  product pipeline analysis  update novocure ltd nvcr  product pipeline analysis  update published by  globaldata published date  dec  category  medical equipments no of pages   pages description table of content check discount summarynovocure ltd novocure is an oncology company that focuses on the development and commercialization of novel therapies for tumor treating fields the companys pipeline products find application in various types of cancer indications such as ovarian cancer malignant melanoma hepatocellular carcinoma breast cancer and small cell lung cancer among others novocure also offers products for other indications such as glioblastoma and diagnosed glioblastoma the company operates along with its subsidiaries located in new hampshire the us and berlin germany it owns and operates a research centre in haifa israel the company also has presence in japan and switzerland novocure is headquartered in jersey the ukthis report is a source for data analysis and actionable intelligence on the companys portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescope the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments the report analyzes all pipeline products in development for the company novocure ltd the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date the report provides detailed description of products in development technical specification and functions the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development marketing and sales strategies by understanding the competitor portfolio to formulate effective research  development strategies develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return plan mergers and acquisitions effectively by identifying key players of the most promising pipeline  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials stage and of development etc identify understand and capitalize the next highvalue products that your competitor would add in its portfolio table of contents table of contents list of tables list of figures novocure ltd company overview novocure ltd company snapshot novocure ltd pipeline products and clinical trials overview novocure ltd pipeline analysis overview key facts novocure ltd  major products and services novocure ltd pipeline products by development stage novocure ltd clinical trials by trial status novocure ltd pipeline products overview optune  brain metastasis optune  brain metastasis product overview optune  brain metastasis clinical trial optune  breast cancer optune  breast cancer product overview optune  cervical cancer optune  cervical cancer product overview optune  colorectal carcinoma optune  colorectal carcinoma product overview optune  gastric adenocarcinoma optune  gastric adenocarcinoma product overview optune  hepatocellular carcinoma optune  hepatocellular carcinoma product overview optune  liver metastases optune  liver metastases product overview optune  malignant melanoma optune  malignant melanoma product overview optune  mesothelioma optune  mesothelioma product overview optune  ovarian cancer optune  ovarian cancer product overview optune  pancreatic cancer optune  pancreatic cancer product overview optune  prostate cancer optune  prostate cancer product overview optune  renal adenocarcinoma optune  renal adenocarcinoma product overview optune  small cell lung cancer optune  small cell lung cancer product overview optune  squamous nonsmall cell lung cancer optune  squamous nonsmall cell lung cancer product overview optune  urinary transitional cell carcinoma optune  urinary transitional cell carcinoma product overview novocure ltd  key competitors novocure ltd  key employees novocure ltd  key employee biographies novocure ltd  locations and subsidiaries head office other locations  subsidiaries recent developments novocure ltd recent developments dec   novocures optune novottfa approved in japan for the treatment of newly diagnosed glioblastoma dec   novocure presents second cohort of phase  pilot panova trial results suggesting tumor treating fields plus nabpaclitaxel and gemcitabine may be safe as firstline treatment and may improve oneyear survival rate of patients with advanced pancreatic dec   novocure presents phase  pilot innovate trial results suggesting tumor treating fields plus paclitaxel may be safe as firstline treatment and may improve survival of patients with recurrent ovarian cancer dec   novocure announces agenda for research and development day on dec   nov   longterm analysis of all  patients enrolled in novocures phase  pivotal trial in newly diagnosed glioblastoma confirms successful interim analysis results and demonstrates superior two and fouryear survival rates nov   united healthcare issues positive coverage decision for optune nov   novocure reports third quarter  financial results and provides company update oct   novocure enrolls first patient in phase  pivotal brain metastases trial sep   cns oncology publishes tumor treating fields treatment planning and patient followup guidelines in glioblastoma sep   novocures executive chairman william doyle to present on tumor treating fields at new york academy of sciences symposium on bioelectronic medicine appendix methodology about globaldata contact us disclaimer list of tables novocure ltd pipeline products and clinical trials overview novocure ltd pipeline products by equipment type novocure ltd pipeline products by indication novocure ltd clinical trials by trial status novocure ltd key facts novocure ltd major products and services novocure ltd number of pipeline products by development stage novocure ltd pipeline products summary by development stage novocure ltd clinical trials by trial status novocure ltd clinical trials summary optune  brain metastasis  product status optune  brain metastasis  product description optune  brain metastasis  a phase ii randomized study of ttfield therapy  khz versus supportive care in nonsmall cell lung cancer patients with  brain metastases following optimal standard local treatment optune  brain metastasis  pilot study of optune novottfa for recurrent atypical and anaplastic meningioma optune  brain metastasis  pivotal openlabel randomized study of radiosurgery with or without tumor treating fields ttfields khz for  brain metastases from nonsmall cell lung cancer nsclc optune  breast cancer  product status optune  breast cancer  product description optune  cervical cancer  product status optune  cervical cancer  product description optune  colorectal carcinoma  product status optune  colorectal carcinoma  product description optune  gastric adenocarcinoma  product status optune  gastric adenocarcinoma  product description optune  hepatocellular carcinoma  product status optune  hepatocellular carcinoma  product description optune  liver metastases  product status optune  liver metastases  product description optune  malignant melanoma  product status optune  malignant melanoma  product description optune  mesothelioma  product status optune  mesothelioma  product description optune  ovarian cancer  product status optune  ovarian cancer  product description optune  pancreatic cancer  product status optune  pancreatic cancer  product description optune  prostate cancer  product status optune  prostate cancer  product description optune  renal adenocarcinoma  product status optune  renal adenocarcinoma  product description optune  small cell lung cancer  product status optune  small cell lung cancer  product description optune  squamous nonsmall cell lung cancer  product status optune  squamous nonsmall cell lung cancer  product description optune  urinary transitional cell carcinoma  product status optune  urinary transitional cell carcinoma  product description novocure ltd key employees novocure ltd key employee biographies table  novocure ltd other locations novocure ltd subsidiaries list of figures novocure ltd pipeline products by development stage novocure ltd clinical trials by trial status  make an enquiry before buying this report please fill the enquiry form below full name  your email  job title  company  phone no  pls affix country code message security code   choose license type  select user license single license user  multiple license user  do you wish to check sample of this report order a sample report have query on this report related news trex did not sprint it walked unhackable web communication to be launched by china tetraphases antibiotic eravacycline succeeds stage clinical trial sperm count in men across developed countries declining sharply study greenland darkens with fear of rising sea level intensifying research assistance we will be happy to help you find what you need please call us or write to us  uscanada toll free tel   email  salesresearchmozus novocure ltd nvcr  product pipeline analysis  update    about us blog contact us faq  usd eur gbp usd ▼ usd eur gbp € eur  usd £ gbp rest of world us toll free  advanced price from €eurusd£gbp view pricing home  categories  company reports select a format  €eurusd£gbp single user electronic pdf  this is a single user license allowing one specific user access to the product the report will be emailed to you the report is sent in pdf format  €eurusd£gbp site license electronic pdf  this is a site license allowing all users within a given geographical location of your organisation access to the product the report will be emailed to you the report is sent in pdf format  €eurusd£gbp enterprisewide electronic pdf  this is an enterprise license allowing all employees within your organisation access to the product the report will be emailed to you the report is sent in pdf format  add to basket order by fax need a quote  our clients have a question email us view faqs recently viewed products partner of research and marketsvaccinating  children in  why choose research and markets worlds largest selection trusted by the best customer focused safe  secure research and markets did an exceptional job providing timely responses the result of this was the delivery of exactly the content requested i would recommended them to any potential customer for their market research needs read more mrs denise jimenez market research analyst sgs tool company novocure ltd nvcr  product pipeline analysis  update id  company profile december   pages globaldata description table of contents companies mentioned formats  faq  of  featured companies beigene ltd ergomed plc oxford biomedica plc vernalis plc more login to access executive summary printer friendly printable pdf brochure send to a friend summarynovocure ltd novocure is an oncology company that focuses on the development and commercialization of novel therapies for tumor treating fields the company’s pipeline products find application in various types of cancer indications such as ovarian cancer malignant melanoma hepatocellular carcinoma breast cancer and small cell lung cancer among others novocure also offers products for other indications such as glioblastoma and diagnosed glioblastoma the company operates along with its subsidiaries located in new hampshire the us and berlin germany it owns and operates a research centre in haifa israel the company also has presence in japan and switzerland novocure is headquartered in jersey the ukthis report is a source for data analysis and actionable intelligence on the company’s portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescope the report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments the report analyzes all pipeline products in development for the company novocure ltd the report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial status the report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch date the report provides detailed description of products in development technical specification and functions the report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape design and develop your product development marketing and sales strategies by understanding the competitor portfolio to formulate effective research  development strategies develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return plan mergers and acquisitions effectively by identifying key players of the most promising pipeline identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials stage and of development etc identify understand and capitalize the next highvalue products that your competitor would add in its portfolio show less read more note product cover images may vary from those shown  of  featured companies beigene ltd ergomed plc oxford biomedica plc vernalis plc more login to access executive summary printer friendly printable pdf brochure send to a friend list of tableslist of figuresnovocure ltd company overviewnovocure ltd company snapshotnovocure ltd pipeline products and clinical trials overviewnovocure ltd  pipeline analysis overview key facts novocure ltd  major products and services novocure ltd pipeline products by development stage novocure ltd clinical trials by trial status novocure ltd pipeline products overview optune  brain metastasis optune  brain metastasis product overview optune  brain metastasis clinical trial optune  breast cancer optune  breast cancer product overview optune  cervical cancer optune  cervical cancer product overview optune  colorectal carcinoma optune  colorectal carcinoma product overview optune  gastric adenocarcinoma optune  gastric adenocarcinoma product overview optune  hepatocellular carcinoma optune  hepatocellular carcinoma product overview optune  liver metastases optune  liver metastases product overview optune  malignant melanoma optune  malignant melanoma product overview optune  mesothelioma optune  mesothelioma product overview optune  ovarian cancer optune  ovarian cancer product overview optune  pancreatic cancer optune  pancreatic cancer product overview optune  prostate cancer optune  prostate cancer product overview optune  renal adenocarcinoma optune  renal adenocarcinoma product overview optune  small cell lung cancer optune  small cell lung cancer product overview optune  squamous nonsmall cell lung cancer optune  squamous nonsmall cell lung cancer product overview optune  urinary transitional cell carcinoma optune  urinary transitional cell carcinoma product overview novocure ltd  key competitors novocure ltd  key employees novocure ltd  key employee biographies novocure ltd  locations and subsidiaries head office other locations  subsidiaries recent developments novocure ltd recent developments dec   novocure’s optune novottfa approved in japan for the treatment of newly diagnosed glioblastoma dec   novocure presents second cohort of phase  pilot panova trial results suggesting tumor treating fields plus nabpaclitaxel and gemcitabine may be safe as firstline treatment and may improve oneyear survival rate of patients with advanced pancreatic dec   novocure presents phase  pilot innovate trial results suggesting tumor treating fields plus paclitaxel may be safe as firstline treatment and may improve survival of patients with recurrent ovarian cancer dec   novocure announces agenda for research and development day on dec   nov   longterm analysis of all  patients enrolled in novocure’s phase  pivotal trial in newly diagnosed glioblastoma confirms successful interim analysis results and demonstrates superior two and fouryear survival rates nov   united healthcare issues positive coverage decision for optune nov   novocure reports third quarter  financial results and provides company update oct   novocure enrolls first patient in phase  pivotal brain metastases trial sep   cns oncology publishes tumor treating fields treatment planning and patient followup guidelines in glioblastoma sep   novocure’s executive chairman william doyle to present on tumor treating fields at new york academy of sciences’ symposium on bioelectronic medicine appendix methodology aboutcontact us disclaimer list of tables novocure ltd pipeline products and clinical trials overviewnovocure ltd pipeline products by equipment typenovocure ltd pipeline products by indicationnovocure ltd clinical trials by trial statusnovocure ltd key facts novocure ltd major products and services novocure ltd number of pipeline products by development stage novocure ltd pipeline products summary by development stage novocure ltd clinical trials by trial status novocure ltd clinical trials summary optune  brain metastasis  product status optune  brain metastasis  product description optune  brain metastasis  a phase ii randomized study of ttfield therapy  khz versus supportive care in nonsmall cell lung cancer patients with  brain metastases following optimal standard local treatment optune  brain metastasis  pilot study of optune novottfa for recurrent atypical and anaplastic meningioma optune  brain metastasis  pivotal openlabel randomized study of radiosurgery with or without tumor treating fields ttfields khz for  brain metastases from nonsmall cell lung cancer nsclc optune  breast cancer  product status optune  breast cancer  product description optune  cervical cancer  product status optune  cervical cancer  product description optune  colorectal carcinoma  product status optune  colorectal carcinoma  product description optune  gastric adenocarcinoma  product status optune  gastric adenocarcinoma  product description optune  hepatocellular carcinoma  product status optune  hepatocellular carcinoma  product description optune  liver metastases  product status optune  liver metastases  product description optune  malignant melanoma  product status optune  malignant melanoma  product description optune  mesothelioma  product status optune  mesothelioma  product description optune  ovarian cancer  product status optune  ovarian cancer  product description optune  pancreatic cancer  product status optune  pancreatic cancer  product description optune  prostate cancer  product status optune  prostate cancer  product description optune  renal adenocarcinoma  product status optune  renal adenocarcinoma  product description optune  small cell lung cancer  product status optune  small cell lung cancer  product description optune  squamous nonsmall cell lung cancer  product status optune  squamous nonsmall cell lung cancer  product description optune  urinary transitional cell carcinoma  product status optune  urinary transitional cell carcinoma  product description novocure ltd key employees novocure ltd key employee biographies table  novocure ltd other locations novocure ltd subsidiaries list of figures novocure ltd pipeline products by development stage novocure ltd clinical trials by trial status note product cover images may vary from those shown  of  loading  of  login to access executive summary printer friendly printable pdf brochure send to a friend vernalis plcoxford biomedica plcergomed plcbeigene ltd note product cover images may vary from those shown  of  note product cover images may vary from those shown related products polynovo biomaterials pty ltd  product pipeline analysis  update  company profile february  from €eurusd£gbp diagnocure inc cur  product pipeline analysis  update  company profile june  from €eurusd£gbp metabolon inc  product pipeline analysis  update  company profile august  from €eurusd£gbp metabolon inc  product pipeline analysis  update  company profile july  from €eurusd£gbp omeros corporation  product pipeline review    company profile december  from €eurusd£gbp somalogic inc  product pipeline analysis  update  company profile july  from €eurusd£gbp somalogic inc  product pipeline analysis  update  company profile september  from €eurusd£gbp myriad genetics inc mygn  product pipeline analysis  update  company profile december  from €eurusd£gbp genomic health inc ghdx  product pipeline analysis  update  company profile march  from €eurusd£gbp polynovo biomaterials pty ltd  product pipeline analysis  update  company profile july  from €eurusd£gbp close novocure ltd nvcr  product pipeline analysis  update close ask a question required information product novocure ltd nvcr  product pipeline analysis  update your question your contact details title mr mrs dr miss ms prof first name last name email address country please select  united states united kingdom germany canada australia  afghanistan albania algeria american samoa andorra angola anguilla antarcticacasey antarcticascott antigua and barbuda argentina armenia aruba ascension island ashmore and cartier islands atlantic east atlantic west australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana brazil british virgin islands brunei bulgaria burkina faso burma burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island clipperton island cocos keeling islands colombia comoros congo cook islands costa rica croatia cuba curaco cyprus czech republic democratic republic of congo denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands islas malvinas faroe islands fiji islands finland france french guiana french polynesia gabon gambia gaza strip georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy ivory coast ivory coast cote divoire jamaica japan jordan kazakhstan kenya kiribati kosovo kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte islands mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria niue norfolk islands north korea northern ireland northern marianas norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar reunion romania russia rwanda saint christopher nevis saint helena saint kitts and nevis saint lucia saint martin saint vincent and the grenadines samoa san marino sao tome saudi arabia scotland senegal serbia serbia and montenegro seychelles sierra leone singapore sint maarten slovakia slovenia solomon islands somalia south africa south korea spain sri lanka sudan suriname swaziland sweden switzerland syria tahiti taiwan tajikistan tanzania thailand togo trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city holy see venezuela vietnam virgin islands wallis and futuna west bank west indies western sahara yemen yugoslavia zaire zambia zimbabwe phone number                                                                                                                                                                                                                                    we request your telephone number so we can contact you in the event we have difficulty reaching you via email we aim to respond to all questions on the same business day close send to a friend  required information friends details full name email address message to friend your contact details full name email address close request a quote please complete the below form and click send request to obtain a pdf quotation and order form this document will be available for immediate download and will also be emailed to you  required information your address address  address  address  city postalzip code country please select  united states united kingdom germany canada australia  afghanistan albania algeria american samoa andorra angola anguilla antarcticacasey antarcticascott antigua and barbuda argentina armenia aruba ascension island ashmore and cartier islands atlantic east atlantic west australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana brazil british virgin islands brunei bulgaria burkina faso burma burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island clipperton island cocos keeling islands colombia comoros congo cook islands costa rica croatia cuba curaco cyprus czech republic democratic republic of congo denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands islas malvinas faroe islands fiji islands finland france french guiana french polynesia gabon gambia gaza strip georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy ivory coast ivory coast cote divoire jamaica japan jordan kazakhstan kenya kiribati kosovo kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte islands mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria niue norfolk islands north korea northern ireland northern marianas norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar reunion romania russia rwanda saint christopher nevis saint helena saint kitts and nevis saint lucia saint martin saint vincent and the grenadines samoa san marino sao tome saudi arabia scotland senegal serbia serbia and montenegro seychelles sierra leone singapore sint maarten slovakia slovenia solomon islands somalia south africa south korea spain sri lanka sudan suriname swaziland sweden switzerland syria tahiti taiwan tajikistan tanzania thailand togo trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city holy see venezuela vietnam virgin islands wallis and futuna west bank west indies western sahara yemen yugoslavia zaire zambia zimbabwe state your details title mr mrs dr miss ms prof first name last name organisation email address phone number                                                                                                                                                                                                                                    po number if applicable product format license format properties price single user electronic pdf the report will be emailed to you the report is sent in pdf format this is a single user license allowing one specific user access to the product €eurusd£gbp site license electronic pdf the report will be emailed to you the report is sent in pdf format this is a site license allowing all users within a given geographical location of your organisation access to the product €eurusd£gbp enterprisewide electronic pdf the report will be emailed to you the report is sent in pdf format this is an enterprise license allowing all employees within your organisation access to the product €eurusd£gbp  the price quoted above is only valid for  days please submit your order within that time frame to avail of this price as all prices are subject to change novocure ltd menu suggested topics subscribe hi sign in register items added to cart your shopping cart is empty visit our store my library topic feeds purchases activity account settings email preferences log out suggested topics hbr store  case studies  finance  accounting novocure ltd case study william a sahlmansarah greene flaherty save share  save share format pdf hardcopy black  white format pdf hardcopy black  white language english english add copyright permissions quantity discounts number of copyright permissions language english quantity buying for your team add to cart description access to case studies expires six months after purchase date publication date november   venture capitalist william doyle must raise  million for a portfolio company with a promising novel cancer therapy just as global capital markets are imploding in the fall of  novocure ltd has developed an electricalfieldbased therapy called tumor treating fields for the treatment of cancerous tumors the therapy has shown significant efficacy with no side effects after five years of testing in human patients doyle believes novocure has the potential to become an important company with a major new cancer therapy platform but must complete pivotal phase iii clinical trials and receive fda approval doyles venture capital firm wfd ventures has invested  million in three rounds to fund pilot clinical trials for glioblastoma and other nonsmall cell lung cancer and the first pivotal clinical trial for glioblastoma additional financing is needed to proceed with the strategically important second pivotal trial in the fall of  doyle was negotiating the final terms of an investment by two prominent hedge funds when the liquidity crisis caused the hedge funds to withdraw from the transaction doyle must now reevaluate his options for securing the needed financing for this promising young company product  pdfeng pages  related topics entrepreneurial finance health how to download to download this product after your purchase simply signin to hbrorg and visit the purchases area of your account education  student discounts educators register as a premium educator at hbspharvardedu  plan a course and save your students up to  with your academic discount students tell your instructors about the savings at hbspharvardedu business bookshelf summaries and excerpts of the latest books special offers and more from harvard business review press sign up signed up loading customers who viewed this item also viewed loading  copies   copies   copies   copies    note quantity pricing discounts will be reflected at checkout prior to submitting your order  copies   copies   copies   copies    note quantity pricing discounts will be reflected at checkout prior to submitting your order  copies   copies   copies   copies    note quantity pricing discounts will be reflected at checkout prior to submitting your order  copies   copies   copies   copies    note quantity pricing discounts will be reflected at checkout prior to submitting your order     –    note quantity pricing discounts will be reflected at checkout prior to submitting your order     –    note quantity pricing discounts will be reflected at checkout prior to submitting your order     –    note quantity pricing discounts will be reflected at checkout prior to submitting your order     –    note quantity pricing discounts will be reflected at checkout prior to submitting your order  list price   off list –  off list   off list –  off list   off list   off list note quantity pricing discounts will be reflected at checkout prior to submitting your order  list price   off list   off list   off list note quantity pricing discounts will be reflected at checkout prior to submitting your order  list price   off list   off list   off list note quantity pricing discounts will be reflected at checkout prior to submitting your order  list price   off list   off list   off list note quantity pricing discounts will be reflected at checkout prior to submitting your order  list price   off list   off list   off list note quantity pricing discounts will be reflected at checkout prior to submitting your order  list price   off list   off list –  off list   off list note quantity pricing discounts will be reflected at checkout prior to submitting your order  list price   off list   off list   off list note quantity pricing discounts will be reflected at checkout prior to submitting your order  list price   off list   off list   off list note quantity pricing discounts will be reflected at checkout prior to submitting your order  list price   off list   off list   off list note quantity pricing discounts will be reflected at checkout prior to submitting your order when you place your first order on hbrorg and enter your credit card information and shipping address speedpay ordering is enabled speedpay is a service that saves the credit card details from your most recent purchase and allows you to reuse that card for future purchases if you click the speedpay button on any product detail page your order will be charged to the most recent credit card information attached to your account and shipped if applicable to the last address we have on file for you for more details educators register as a premium educator at hbspharvardedu plan a course and save your students up to  with your academic discount students tell your instructors about the savings at hbspharvardedu    each   each   each   each   each note quantity pricing discounts will be reflected at checkout prior to submitting your order if you need to make additional copies to distribute please purchase copyright permission ebook a digital book provided in three formats pdf epub and mobi for the price of one accessible within “my library” upon purchase hardcopy paperback softbound magazine physical copy shipped from our warehouse to your requested shipping location pdf pdf digital file accessible within “my library” upon purchase bundle a themed collection containing two or more items at a special savings note some of our products are available in other languages besides english for example a “spanish pdf” format means you will receive a pdf in the spanish language a security code is added protection against credit card fraud it is a  or  digit number appearing on the front or back of your credit card see examples below visa and mastercard the security code has  digits and appears on the back of the card in the signature panel american express the card identification number ciddbc is a fourdigit nonembossed flat number that is printed on every american express card the ciddbc is always located above the embossed raised account number on the face of the card in some instances the ciddbc is located on the left side of the card but is always above the account number some cards have a fourdigit number embossed below the account number but this is not the ciddbc if you have a promotion code please enter it below this promotion code field is case sensitive so please type all capital letters this product is intended for individual use only to learn more about volume discounts for organizations and license opportunities for consultants contact lindseydietrichharvardbusinessorg unable to locate your subscription account  click here nvcrnasdaq gs stock quote  novocure ltd  bloomberg markets error could not add to watchlist x  watchlist novocure ltd nvcrus nasdaq gs usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap b usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry health care equipment  services  price change  related videos there are currently no related videos for this ticker please check back later company news press releases  novocure glioblastoma drug offers survival benefits  investopedia there are currently no news stories for this ticker please check back later  hours ago novocure reports second quarter  financial results and provides company update  novocure™ announces a phase b clinical trial to evaluate the safety of marizomib and temozolomide in combination with  novocure’s optune® now available at more than  cancer treatment centers in the us  data on delivery of tumor treating fields to be presented at the th annual international conference of the ieee engineering in  novocure to report second quarter  financial results  novocure to present three abstracts on tumor treating fields and pancreatic cancer at the european society for medical oncology  novocure announces change to presentation time at the jmp securities  life sciences conference  first patient enrolled in rtog trial of optune® together with bevacizumab for patients with bevacizumabrefractory recurrent  health care service corporation issues positive coverage decision for optune  novocure to present at the jmp securities  life sciences conference there are currently no press releases for this ticker please check back later profile novocure limited is an oncology company the company researches and develops novel technologies for the treatment of cancer novocure serves the healthcare industry worldwide address le masurier housela rue le masuriersaint helier je yejersey channel islands phone  website wwwnovocurecom executives board members william f doyle bill chairman wilhelmus groenhuysen wilco chief financial officer asaf danziger chief executive officer michael ambrogi mike chief operating officer eilon kirson chief science officer show more cancer trial with electric fields  novocure ttfields tumor treating fields ttfields are low intensity alternating electric fields tuned to disrupt the division process of cancer cells novocure ltd is the sponsor of clinical trials testing ttfields in several cancers ttfields ttfields are delivered to the region of the tumor using a portable medical device for continuous home use the system applies ttfields noninvasively and was designed to allow patients to maintain their lifestyle while receiving ttfields using ttfields novocure is developing ttfields for different cancer diseases novocure maintains this website in order to assist patients their family members and caregivers in accessing clinical trial sites for potential participation in ongoing trials patients should always consult with their treating physician about their treatment options novocure clinical trials a phase iii study of ttfields combined with chemotherapy for advanced nonsmallcell lung cancer more a phase ii study of ttfields combined with chemotherapy for mesothelioma more a phase ii study of ttfields combined with chemotherapy for recurrent ovarian cancer more a phase ii study of ttfields combined with chemotherapy for newlydiagnosed pancreatic cancer more a phase ii study of ttfields following local therapy for  brain metastases from nonsmallcell lung cancer more a phase iii study of ttfields following stereotactic radiosurgery for  brain metastases from nonsmallcell lung cancer more ttfields ttfields have been approved by fda for the treatment of adult patients suffering from newly diagnosed and recurrent glioblastoma ttfields is currently being tested for other cancers in various clinical trials presented in this website ttfields is experimental for all indications mentioned in those clinical trials and has not been approved for their treatment